DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Cash and Bank History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹3,715 Cr | ₹3,980 Cr | ₹4,214 Cr | ₹2,819 Cr | ₹2,156 Cr |
What is the latest Cash and Bank ratio of DIVIS LABORATORIES ?
| Year | Cash and Bank |
|---|---|
| Mar2025 | ₹3,715 Cr |
| Mar2024 | ₹3,980 Cr |
| Mar2023 | ₹4,214 Cr |
| Mar2022 | ₹2,819 Cr |
| Mar2021 | ₹2,156 Cr |
How is Cash and Bank of DIVIS LABORATORIES Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,715 Cr | -6.66 | |
| Mar2024 | ₹3,980 Cr | -5.55 | |
| Mar2023 | ₹4,214 Cr | 49.49 | |
| Mar2022 | ₹2,819 Cr | 30.74 | |
| Mar2021 | ₹2,156 Cr | - | |
Compare Cash and Bank of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹159,375.7 Cr | -5.6% | -7.3% | 1.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,905.0 Cr | -5.2% | -7.6% | -8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,788.0 Cr | -0.6% | 4.8% | 25% | Stock Analytics | |
| CIPLA | ₹110,628.0 Cr | -4.5% | -9.7% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,441.5 Cr | -2.6% | -9.7% | -10.5% | Stock Analytics | |
| MANKIND PHARMA | ₹86,682.9 Cr | -6.4% | -3.4% | -16.6% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -5.6% |
-7.3% |
1.5% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses